Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Change in Accured Expenses (2020 - 2026)

Biomea Fusion (BMEA) posted Change in Accured Expenses of -$3.0 million for Q1 2026, down 51.04% sequentially from -$2.0 million in Q4 2025, and down 173.72% YoY from $4.0 million in Q1 2025.

Biomea Fusion (BMEA) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Change in Accured Expenses for 7 years, with the latest figure at -$3.0 million in Q1 2026.

  • Quarterly Change in Accured Expenses fell 173.72% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.2 million (down 8.17% YoY) and the FY2025 annual result came in at -$255000.0, up 96.29% from the prior year.
  • Change in Accured Expenses slipped to -$3.0 million in Q1 2026 per BMEA's latest filing, from -$2.0 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $4.0 million in Q3 2022 and troughed at -$9.2 million in Q4 2024.
  • A 5-year average of $41117.6 and a median of $400000.0 in 2025 frame the typical range for Change in Accured Expenses.
  • The widest YoY moves for Change in Accured Expenses: up 566.1% in 2024, down 375.39% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $1.3 million in 2022, then surged by 164.98% to $3.4 million in 2023, then tumbled by 375.39% to -$9.2 million in 2024, then jumped by 78.73% to -$2.0 million in 2025, then tumbled by 51.04% to -$3.0 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$3.0 million, -$2.0 million, and $400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Biomea Fusion 97.69 Mn 97.69 Mn - 2.86 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.86 Mn
Jun 30, 2026 2.86 Mn
Mar 31, 2026 -2.97 Mn
Mar 31, 2026 -2.97 Mn
Dec 31, 2025 -1.96 Mn
Dec 31, 2025 -1.96 Mn
Sep 30, 2025 400,000.00
Sep 30, 2025 400,000.00
Jun 30, 2025 -2.71 Mn
Jun 30, 2025 -2.71 Mn
Mar 31, 2025 4.02 Mn
Mar 31, 2025 4.02 Mn
Dec 31, 2024 -9.23 Mn
Dec 31, 2024 -9.23 Mn
Sep 30, 2024 -153,000.00
Sep 30, 2024 -153,000.00
Jun 30, 2024 -1.33 Mn
Jun 30, 2024 -1.33 Mn
Mar 31, 2024 3.84 Mn
Mar 31, 2024 3.84 Mn